Loading data for IRWD — first visit, this takes a few seconds.
Ironwood Pharmaceuticals ... (IRWD)
NasdaqGS: IRWD
· Real-Time Price · USD
4.29
+0.15 (3.62%)
At close: Aug 20, 2026, 8:00 PM
4.22
+1.93%
After-hours: 7:30 PM
The price, the headline numbers and the latest news, in one place.
Ironwood Pharmaceuticals Inc. (IRWD) Stock Price, Analysis & Data
3.62% (1D)
No data available
| Bid | 3.61 |
| Market Cap | 684.09M |
| Revenue (ttm) | 389.32M |
| Net Income (ttm) | 129.87M |
| 0.21 | |
| 0.79 | |
| 5.24 | |
| 2.81 | |
| P/B (ttm) | -3.14 |
| P/S (ttm) | 1.76 |
| Earnings Date | Feb 15, 2024 |
| Ask | 4.85 |
| Volume | 2,207,373 |
| Avg. Volume (20D) | 2,313,964 |
| Open | 4.22 |
| Previous Close | 4.14 |
| Day's Range | 4.18 - 4.30 |
| 52-Week Range | 1.01 - 5.78 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About IRWD
Ironwood Pharmaceuticals, Inc., a biotechnology company, focuses on the development and commercialization of therapies for gastrointestinal (GI) and rare diseases in the United States and internationally. It sells linaclotide, a guanylate cyclase type-C (GC-C) agonist for the treatment of adults suffering from irritable bowel syndrome with constipation or chronic idiopathic constipation, as well as for pediatric patients suffering from functional...
Sector Healthcare
IPO Date Feb 3, 2010
Employees 100
Stock Exchange NasdaqGS
Ticker Symbol IRWD
Website https://ironwoodpharma.com
Financial Performance
In 2025, Ironwood Pharmaceuticals's revenue was 296.15M, a decrease of -15.72% compared to the previous year's 351.41M. Earnings were 24.02M, an increase of 2,629.2%.
Financial StatementsEarnings Surprise
Ironwood Pharmaceuticals has released their quarterly earnings on Aug 6, 2026:
Ironwood Pharmaceuticals Inc. is scheduled to release its earnings on Feb 15, 2024, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2